Company Filing History:
Years Active: 2021
Title: The Innovations of Alexandre Ambrogelly
Introduction
Alexandre Ambrogelly is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His work has implications for various therapeutic applications, showcasing the intersection of innovation and healthcare.
Latest Patents
Ambrogelly holds a patent for FLT3L-Fc fusion proteins. This patent includes polynucleotides encoding such fusion proteins, expression cassettes, vectors, cells, and kits comprising these fusion proteins. The methods of using these proteins are also outlined in his patent, highlighting their potential in medical treatments.
Career Highlights
Ambrogelly is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
He has collaborated with notable colleagues, including Manuel Baca and Brian A. Carr. These partnerships enhance the research environment and contribute to the advancement of their collective work in biotechnology.
Conclusion
Alexandre Ambrogelly's contributions to the field of biotechnology through his patent on FLT3L-Fc fusion proteins exemplify the importance of innovation in healthcare. His work at Gilead Sciences, Inc. and collaborations with esteemed colleagues further underscore his impact in this vital area of research.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.